Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
2.400
-0.030 (-1.23%)
At close: Feb 20, 2026, 4:00 PM EST
2.420
+0.020 (0.83%)
After-hours: Feb 20, 2026, 7:56 PM EST
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $32.35 million as of February 20, 2026. Its market cap has decreased by -20.75% in one year.
Market Cap
32.35M
Enterprise Value
33.25M
1-Year Change
-20.75%
Ranking
Category
Stock Price
$2.40
Market Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $32.35M, a decrease of -63.50%. That is a compound annual growth rate of -19.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 32.35M | 128.80% |
| Dec 31, 2025 | 14.14M | -61.17% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
| Jun 28, 2021 | 88.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Palatin Technologies | 35.14M |
| INmune Bio | 35.09M |
| Werewolf Therapeutics | 34.91M |
| Actinium Pharmaceuticals | 34.63M |
| RenovoRx | 34.47M |
| Sensei Biotherapeutics | 34.45M |
| Tvardi Therapeutics | 33.68M |
| Kyntra Bio | 31.72M |